Skip to main content

Table 2 Virological response in the studied patients

From: Effect of sofosbuvir plus daclatasvir on virological response and liver function tests as a line of treatment for HCV related cirrhosis (a prospective cohort study)

Viral loadStudied patients (N = 240)
Viral load on 4th week 
 < 15 IU/L156 (65.0%)
 > 15 IU/L84 (35.0%)
Viral load on 8th week 
 < 15 IU/L212 (88.3%)
 > 15 IU/L28 (11.7%)
Viral load on 12th week 
 < 15 IU/L240 (100.0%)
 > 15 IU/L0 (0.0%)
Viral load on 24th week 
 < 15 IU/L240 (100.0%)
 > 15 IU/L0 (0.0%)
Viral load on 12th week post-treatment 
 < 15 IU/L231 (96.3%)
 > 15 IU/L9 (3.7%)
SVR 
 Yes231 (96.3%)
 No9 (3.7%)
  1. Data are presented as number (%)
  2. SVR sustained virological response